Evidence map›Paper›PMID 39164329›Full record

ArticleScientific reports2024

Visualisation of in vivo protein synthesis during mycobacterial infection through [

Sebastian Eigner, Janke Kleynhans, Dennis R Beckford Vera, Mike M Sathekge, Katerina Eigner Henke, Thomas Ebenhan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sebastian EignerDepartment of Radiopharmaceuticals, Nuclear Physics Institute of the Academy of Sciences of the Czech Republic, Husinec-Rez 130, 25068, Husinec-Rez, Czech Republic.
Janke KleynhansNuclear Medicine Research Infrastructure NPC, Pretoria, 0001, South Africa.
Dennis R Beckford VeraDepartment of Radiopharmaceuticals, Nuclear Physics Institute of the Academy of Sciences of the Czech Republic, Husinec-Rez 130, 25068, Husinec-Rez, Czech Republic.
Mike M SathekgeNuclear Medicine Research Infrastructure NPC, Pretoria, 0001, South Africa.
Katerina Eigner HenkeDepartment of Radiopharmacy, Charles University Prague, 11000, Prague, Czech Republic.
Thomas EbenhanNuclear Medicine Research Infrastructure NPC, Pretoria, 0001, South Africa. thomas.ebenhan@up.ac.za.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiolabelled puromycin analogues will allow the quantification of protein synthesis through nuclear medicine-based imaging. A particularly useful application could be the non-invasive longitudinal visualisation of mycobacterial activity through direct quantification of puromycin binding. This study assesses the value of [

Indexed as

Gallium RadioisotopesMagnetic Resonance ImagingMycobacterium bovisPositron-Emission TomographyRadiopharmaceuticalsAnimalsFemaleHeterocyclic Compounds, 1-RingMiceMice, SCIDMycobacterium InfectionsOrganometallic CompoundsTuberculosisGallium RadioisotopesHeterocyclic Compounds, 1-RingOrganometallic CompoundsRadiopharmaceuticalsFluorodeoxyglucoseGallium-68Molecular imagingMycobacterium tuberculosisPositron emission tomography/magnetic resonance imaging

Identifiers

PMID39164329
PMCPMC11335739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.